Investing

Zentalis Pharmaceuticals : ZNTL

ZNTL

Stock Data

$4.09

$0.08 (2.00%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Zentalis Pharmaceuticals Inc is a New York-based biopharmaceutical company focused on developing innovative small molecule treatments for cancer. With a robust pipeline, including ZN-c3 for various solid tumors and hematological malignancies, and ZN-d5 for blood-related disorders, Zentalis is at the forefront of cancer therapy research. Their work spans multiple clinical trial stages, targeting conditions like ovarian, colorectal, and pancreatic cancers. Collaborating with industry giants like Pfizer and GlaxoSmithKline, Zentalis is committed to advancing cancer treatment options through scientific discovery and strategic partnerships.

All Zentalis Pharmaceuticals Articles

1 Article

Trey Thoelcke | Jan 13, 2026 at 8:45 AM EST

Mitsui Sumitomo Continues to Build WR Berkley Stake

W.R. Berkley and Navan have just seen some huge insider purchases. have seen some huge insider purchases, and there were…